C07F 9/4419
Amides of aromatic acids
Official title: {Amides of aromatic acids (P-C aromatic linkage)}
C07F9/4419 (Amides of aromatic acids) appears on 22 US grants and 18 published applications in this corpus.
Search patents in C07F- Granted patents
- 22
- Published applications
- 18
- Assignees
- 12
- Inventors
- 52
- Latest grant
- 10 Aug 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 2 |
| 2013 | 2 | 3 |
| 2014 | 1 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 1 | 4 |
| 2019 | 2 | 4 |
| 2020 | 4 | 1 |
| 2021 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Chiral phosphoramidimidates and derivatives thereof10 Aug 2021US 11,084,834 B2Studiengesellschaft Kohle mbH
- Phospholidines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer18 Aug 2020US 10,745,429 B2Unity Biotechnology, Inc.
- Phosphonamidates that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer11 Aug 2020US 10,738,042 B2Unity Biotechnology, Inc.
- Acyl phosphonamidates and acyl benzylamines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer7 Jul 2020US 10,703,745 B2Unity Biotechnology, Inc.
- Flame-retardant vanillin-derived small molecules23 Jun 2020US 10,689,579 B2International Business Machines Corporation
- Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer11 Mar 2021US 2021/0070788 A1
- Phosphonamidates that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer24 Dec 2020US 2020/0399259 A1
- Acyl Phosphonamidates and Acyl Benzylamines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer5 Dec 2019US 2019/0367496 A1Unity Biotechnology, Inc.
- Phosphonamidates that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating Cancer31 Oct 2019US 2019/0330199 A1Unity Biotechnology, Inc.
- Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating Cancer31 Oct 2019US 2019/0330250 A1Unity Biotechnology, Inc.
Most cited
By later US patents
- 2-Substituted 5-phenoxyphenylphosphonic acid derivatives21US 4,322,375 ACiba-Geigy Corporation · 1982
- Phosphinate ruthenium complexes4US 8,309,737 B2Idenix Pharmaceuticals, Inc. · 2012
- Phosphonamides, process for producing the same, and use thereof3US 7,829,044 B2Japan Science and Technology Agency · 2010
- Chiral phosphoramidimidates and derivatives thereof2US 11,084,834 B2Studiengesellschaft Kohle mbH · 2021
- Herbicidally active 2-substituted 5-phenoxyphenylphosphonic acid esters2US 4,391,624 ACiba-Geigy Corporation · 1983